New York Oncology Hematology, P.C. ( Site 0129) — Albany, New York

New York Oncology Hematology, P.C. ( Site 0129) is a clinical research site located in Albany, New York, United States 12206.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology, P.C. ( Site 0129) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diffuse Large B-Cell Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology, P.C. ( Site 0129)?

New York Oncology Hematology, P.C. ( Site 0129) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology, P.C. ( Site 0129) conducted?

New York Oncology Hematology, P.C. ( Site 0129) has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Large B-Cell Lymphoma.

Is New York Oncology Hematology, P.C. ( Site 0129) accredited by Crixeo Health?

New York Oncology Hematology, P.C. ( Site 0129) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology, P.C. ( Site 0129)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.